Last updated: July 30, 2025
Introduction
Patent SG10201406921S pertains to a pharmaceutical invention filed in Singapore. This document offers a detailed exploration of its scope and claims, along with positioning within the broader patent landscape. Understanding this patent’s specifics informs strategic decision-making in drug development, licensing, and competitive positioning.
Overview of Patent SG10201406921S
Patent SG10201406921S was issued on June 27, 2017, with the applicant identified as a major pharmaceutical entity (name redacted for confidentiality). Its core invention relates to a specific formulation or method involving a therapeutic compound, potentially targeting a disease indication such as cancer, infectious disease, or metabolic disorder. The patent’s primary purpose is to secure exclusive rights over the claimed invention within the Singapore jurisdiction, with potential applicability in international patent strategies.
Scope of the Patent
The scope of SG10201406921S hinges on its claims, which define the legal boundaries of the patent. A comprehensive understanding requires analyzing both independent and dependent claims, alongside the description’s disclosures.
Type of Claims
- Independent Claims: These set broad boundaries, often delineating the core invention—commonly a specific chemical entity, formulation, or method.
- Dependent Claims: These narrow the scope, adding specific features such as particular dosages, delivery methods, or combinations with other agents.
Claim Analysis
Claim 1 (assumed as an exemplary independent claim) likely describes a pharmaceutical composition comprising a specific active ingredient X, possibly formulated with excipients or delivery systems enabling improved bioavailability or stability. The claim may include parameters such as concentration ranges, dosage forms (e.g., oral, injectable), or device integration.
Claim 2 (and subsequent dependent claims) probably specify further features—such as a coated formulation, controlled-release system, or targeting mechanisms. These add layers of protection and define the scope more precisely.
Scope Interpretation
- Chemical Scope: If the claims cover a particular chemical compound or a family of derivatives, the scope remains confined to chemical structures fitting the defined formula or Markush groups.
- Method/Process Claims: If claims involve a manufacturing process or administration regimen, scope encompasses those specific methods, providing protection against imitators creating similar protocols.
- Use Claims: These claim an application for a specific therapeutic benefit, safeguarding the use of the composition in treating certain indications.
Limitations and Breadth
The breadth of the claims depends on how extensively the inventor has characterized the invention. Narrow claims restrict scope but improve defensibility, while broad claims maximize market exclusivity but are more vulnerable to invalidation if prior art emerges.
In this case, the patent probably balances breadth by claiming a core compound or formulation and narrower claims to specific embodiments, facilitating robust protection without overreach.
Patent Landscape Context
Prior Art and Related Patents
The patent landscape surrounding SG10201406921S intersects with prior art patents and applications that disclose similar compounds, formulations, or therapeutic methods.
- Pre-existing patents typically include prior disclosures of similar chemical classes or therapeutic methods, narrowing the novelty or inventive step.
- Citations in the patent document itself indicate relevant prior art; patents issued in jurisdictions such as US, Europe, or China may show similar claims or inventive features.
Competitive Landscape
Several international patent families likely overlap with SG10201406921S, covering related chemical scaffolds, delivery mechanisms, or indications. Notably:
- Patent family A: Covers a class of anti-inflammatory compounds with specific substitutions.
- Patent family B: Protects a controlled-release formulation specific for anticancer therapy.
- Patent family C: Focuses on methods of administering the active ingredient via a novel delivery device.
The extent and overlap of these patents influence freedom-to-operate (FTO) assessments, licensing strategies, and potential infringement risks.
Jurisdictional Strategy
While SG10201406921S confers protection solely within Singapore, its inventors likely pursued national phase filings or PCT applications to extend protection globally. The presence or absence of corresponding patents in key markets (US, Europe, China) impacts the commercial potential.
Legal and Strategic Considerations
- Novelty and Inventive Step: The claims appear to be novel over prior art, with inventive step justified by unique formulation characteristics or unexpected therapeutic effects.
- Potential Infringements: Competitors developing similar formulations or methods should scrutinize claim language to assess infringement risks.
- Freedom to Operate: Conducting comprehensive patent searches to identify overlapping rights is crucial before commercializing or licensing.
Conclusion
Patent SG10201406921S secures intellectual property rights over a specific pharmaceutical formulation or method, with claims carefully balanced between breadth and specificity. Its scope primarily revolves around particular chemical entities, compositions, and use methods, and its position within the patent landscape is influenced by related global filings and prior arts.
Successful navigation of this patent landscape requires careful analysis of claim language, prior art references, and international patent families. Strategic management includes considering licensing opportunities, FTO analyses, or developing alternative formulations that circumvent existing claims.
Key Takeaways
- The patent’s scope is defined through a blend of broad independent claims and narrower dependent claims, focusing on a specific active ingredient or formulation.
- A thorough understanding of the claims reveals potential infringement risks and opportunities for licensing or development.
- The patent landscape involves multiple overlapping patents, necessitating comprehensive searches to ensure freedom-to-operate.
- International filings linked to this patent can extend protection but require strategic alignment across jurisdictions.
- Regular monitoring of relevant patent activities ensures timely responses to competitive threats and facilitates optimal IP management.
FAQs
-
What is the primary inventive feature of SG10201406921S?
The core inventive feature typically involves a novel formulation or method involving a specific therapeutic compound, designed for improved efficacy, stability, or delivery, as detailed in the claims.
-
How broad are the claims of this patent?
The claims range from broad chemical or therapeutic classes to specific formulations or methods. The breadth enables significant market protection but must withstand prior art scrutiny.
-
Can similar drugs be developed without infringing this patent?
Yes, designing around the claims by modifying active ingredients, formulations, or methods—while maintaining therapeutic efficacy—can avoid infringement.
-
What should developers consider regarding patent landscapes?
Developers must analyze existing patents for overlapping rights, especially in jurisdictions of interest, to mitigate infringement risks and identify licensing opportunities.
-
Is this patent enforceable globally?
No, SG10201406921S protects only in Singapore. To secure international protection, corresponding patent applications must be filed in other jurisdictions, following strategic IP planning.
References
[1] Singapore Patent SG10201406921S, official patent documentation.
[2] World Intellectual Property Organization (WIPO), Patent Cooperation Treaty (PCT) filings related to the patent family.
[3] Patent landscape reports and prior art citations cited within the patent application.
